67298 Federal Register / Vol. 71, No.
224 / Tuesday, November 21, 2006 / Rules and Regulations
airspace on users of airspace in the
vicinity of Cedar Springs, GA, notice
and public procedure under 5 U.S.C.
553(b) are not necessary. Designations
for Class E airspace areas extending
upward from 700 feet or more above the
surface of the earth are published in
paragraph 6005 of FAA Order 7400.9P,
dated September 16, 2006, and effective
September 16, 2006, which is
incorporated by reference in 14 CFR
71.1. The Class E airspace designations
listed in this document will be
published subsequently in the Order.
The Rule
This amendment to part 71 of the
Federal Aviation Regulations (14 CFR
part 71) removes Class E5 airspace at
Cedar Springs, GA.
The FAA has determined that this
regulation only involves an established
body of technical regulations for which
frequent and routine amendments are
necessary to keep them operationally
currently. If, therefore, (1) Is not a
‘‘significant regulatory action’’ under
Executive Order 12866; (2) is not a
‘‘significant rule’’ under DOT
Regulatory Policies and Procedures (44
FR 11034; February 26, 1979); and (3)
does not warrant preparation of a
regulatory evaluation as the anticipated
impact is so minimal. Since this is a
routine matter that will only affect air
traffic procedures and air navigation, it
is certified that this rule will not have
a significant economic impact on a
substantial number of small entities
under the criteria of the regulatory
Flexibility Act.
List of Subjects in 14 CFR Part 71
Airspace, Incorporation by reference,
Navigation (air).
Adoption of the Amendment
■ In consideration of the foregoing, the
Federal Aviation Administration
amends 14 CFR part 71 as follows:
PART 71—DESIGNATION OF CLASS A,
CLASS B, CLASS C, CLASS D AND
CLASS E AIRSPACE AREAS;
AIRWAYS; AND REPORTING POINTS
■ 1. The authority citation for 14 CFR
part 71 continues to read as follows:
Authority: 49 U.S.C. 106(g); 40103, 40113,
40120; EO 10854, 24 FR 9565, 3 CFR, 1959–
1963 Comp., p. 389; 14 CFR 11.69.
§ 71.1 [Amended]
cprice-sewell on PROD1PC66 with RULES
■ 2. The incorporation by reference in
14 CFR 71.1 of Federal Aviation
Administration Order 7400.9P, Airspace
Designations and Reporting Points,
dated September 16, 2006, and effective
VerDate Aug<31>2005 14:15 Nov 20, 2006 Jkt 211001
September 16, 2006, is amended as
follows:
Paragraph 6005 Class E Airspace Areas
Extending Upward from 700 feet or More
Above the Surface on the Earth.
* * * * * summary of safety and effectiveness
ASO GA E 5 Cedar Springs, GA [Remove]
Cedar Springs, Georgia-Pacific Airport, GA
(Lat. 31°08′26″ N, long. 85°02′48″ W)
That airspace extending upward from 700
feet or more above the surface of the earth
within a 6.4-mile radius of Georgia-Pacific
Airport.
* * * * *
Issued in College Park, Georgia, on October
26, 2006.
Mark D. Ward,
Group Manager, System Support, Eastern
Service Center.
[FR Doc. 06–9231 Filed 11–21–06; 8:45 am]
BILLING CODE 4910–13–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
21 CFR Part 520
Oral Dosage Form New Animal Drugs;
Ivermectin Paste
AGENCY: Food and Drug Administration,
HHS.
ACTION: Final rule.
SUMMARY: The Food and Drug
Administration (FDA) is amending the
animal drug regulations to reflect
approval of a supplemental abbreviated
new animal drug application (ANADA)
filed by Virbac AH, Inc. The
supplemental ANADA provides revised
labeling for oral use of generic
ivermectin paste in horses that conforms
to the pioneer product label.
DATES: This rule is effective November
21, 2006.
FOR FURTHER INFORMATION CONTACT: John
K. Harshman, Center for Veterinary
Medicine (HFV–104), Food and Drug
Administration, 7500 Standish Pl.,
Rockville, MD 20855, 301–827–0169, e-
mail: john.harshman@fda.hhs.gov.
SUPPLEMENTARY INFORMATION: Virbac
AH, Inc., 3200 Meacham Blvd., Ft.
Worth, TX 76137, filed a supplement to
ANADA 200–320 for EQUELL
(ivermectin) Paste 1.87% that provides
revised labeling for oral use of generic
ivermectin paste in horses that conforms
to the pioneer product label. The
supplemental application is approved as
of October 24, 2006, and 21 CFR
520.1192 is amended to reflect the
approval. The basis of approval is
PO 00000 Frm 00004 Fmt 4700 Sfmt 4700 E:\FR\FM\21NOR1.SGM
discussed in the freedom of information
summary.
In accordance with the freedom of
information provisions of 21 CFR part
20 and 21 CFR 514.11(e)(2)(ii), a
data and information submitted to
support approval of this application
may be seen in the Division of Dockets
Management (HFA–305), Food and Drug
Administration, 5630 Fishers Lane, rm.
1061, Rockville, MD 20852, between 9
a.m. and 4 p.m., Monday through
Friday.
FDA has determined under 21 CFR
25.33(a)(1) that this action is of a type
that does not individually or
cumulatively have a significant effect on
the human environment. Therefore,
neither an environmental assessment
nor an environmental impact statement
is required.
This rule does not meet the definition
of ‘‘rule’’ in 5 U.S.C. 804(3)(A) because
it is a rule of ‘‘particular applicability.’’
Therefore, it is not subject to the
congressional review requirements in 5
U.S.C. 801–808.
List of Subjects in 21 CFR Part 520
Animal drugs.
■ Therefore, under the Federal Food,
Drug, and Cosmetic Act and under
authority delegated to the Commissioner
of Food and Drugs and redelegated to
the Center for Veterinary Medicine, 21
CFR part 520 is amended as follows:
PART 520—ORAL DOSAGE FORM
NEW ANIMAL DRUGS
■ 1. The authority citation for 21 CFR
part 520 continues to read as follows:
Authority: 21 U.S.C. 360b.
§ 520.1192 [Amended]
■ 2. In § 520.1192, in paragraph (b)(2)
remove ‘‘Nos. 051311 and’’ and add in
its place ‘‘No.’’; and in paragraph (b)(4)
remove ‘‘No.’’ and add in its place ‘‘Nos.
051311 and’’.
Dated: November 3, 2006.
Steven D. Vaughn,
Director, Office of New Animal Drug
Evaluation, Center for Veterinary Medicine.
[FR Doc. E6–19616 Filed 11–20–06; 8:45 am]
BILLING CODE 4160–01–S
21NOR1